中文 | English
Return
Total: 60 , 1/6
Show Home Prev Next End page: GO
MeSH:(Lung Neoplasms/*drug therapy/genetics/pathology)

1.Research Advances of Pan-negative Type of Non-small Cell Lung Cancer.

Li SUN ; Zhicheng XIONG ; Chengbo HAN

Chinese Journal of Lung Cancer 2018;21(2):129-138

2.Research Progress on Pathogenic Mechanism and Potential Therapeutic Drugs of 
Idiopathic Pulmonary Fibrosis Complicated with Non-small Cell Lung Cancer.

Ting XIAO ; Jiali BAO ; Xiangning LIU ; Hui HUANG ; Honggang ZHOU

Chinese Journal of Lung Cancer 2022;25(10):756-763

3.Research Progress of Targeted Therapy for BRAF Mutation 
in Advanced Non-small Cell Lung Cancer.

Xia LIU ; Diansheng ZHONG

Chinese Journal of Lung Cancer 2018;21(8):635-640

4.Research Advances of Ang-2 in Non-small Cell Lung Cancer.

Xin HUA ; Xiaoli ZHU

Chinese Journal of Lung Cancer 2018;21(11):868-874

5.Mechanisms of Resistance to the Third-generation Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Non-small Cell Lung Cancer.

Lianfang NI ; Ligong NIE

Chinese Journal of Lung Cancer 2018;21(2):110-115

6.The relationship between cisplatin-induced apoptosis and p53, bcl-2 and bax expression in human lung cancer cells.

Ji Youn HAN ; Yeun Jun CHUNG ; Sung Won PARK ; Jung Soo KIM ; Mun Gan RHYU ; Hoon Kyo KIM ; Kyung Shick LEE

The Korean Journal of Internal Medicine 1999;14(1):42-52

7.A Case Report of Advanced Lung Adenocarcinoma Harboring KRAS Mutation 
Treated with Anlotinib.

Yudong SU ; Zhaoting MENG ; Xiaoyan XU ; XinYue WANG ; Ran ZUO ; Yunxia HOU ; Kai LI ; Peng CHEN

Chinese Journal of Lung Cancer 2018;21(5):428-430

8.Disparities of EGFR mutations between Biopsy and Rebiopsy in Non-small Cell Lung Cancer Patients.

Hui LI ; Shi YAN ; Xianhong LIU ; Ying LIU ; Lixia MA ; Ying WANG ; Yan LIU ; Ying CHENG

Chinese Journal of Lung Cancer 2018;21(11):821-827

9.EGFR mutation predicts response and prognosis in iressa-treated advanced-stage non-small cell lung cancer.

Yu HAN ; Jian-ming XU ; Hai-qing DUAN ; San-tai SONG ; Xiao-qing LIU ; Yang ZHANG ; Jing-sheng ZHANG

Chinese Journal of Oncology 2007;29(4):278-283

10.Lung Squamous Cell Carcinoma with EML4-ALK Fusion and TP53 Co-mutation 
Treated with Ensartinib: A Case Report and Literature Review.

Donglai LV ; Chunwei XU ; Chong WANG ; Qiuju SANG

Chinese Journal of Lung Cancer 2023;26(1):78-82

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 60 , 1/6 Show Home Prev Next End page: GO